Challenges to the development of bryostatin-type anticancer drugs based on the activation mechanism of protein kinase Cδ.
- Published in:
- Medicinal Research Reviews, 2012, v. 32, n. 3, p. 518, doi. 10.1002/med.20220
- By:
- Publication type:
- Article
Works matching IS 01986325 AND DT 2012 AND VI 32 AND IP 3
Results: 7
1
2
Tetraoxanes: Synthetic and Medicinal Chemistry Perspective.
- Published in:
- Medicinal Research Reviews, 2012, v. 32, n. 3, p. 581, doi. 10.1002/med.20223
- By:
- Publication type:
- Article
3
Bone Metastases: Molecular Mechanisms and Novel Therapeutic Interventions.
- Published in:
- Medicinal Research Reviews, 2012, v. 32, n. 3, p. 611, doi. 10.1002/med.20224
- By:
- Publication type:
- Article
4
Endomorphins: potential roles and therapeutic indications in the development of opioid peptide analgesic drugs.
- Published in:
- Medicinal Research Reviews, 2012, v. 32, n. 3, p. 536, doi. 10.1002/med.20222
- By:
- Publication type:
- Article
5
Recognition of Damaged DNA: Structure and Dynamic Markers.
- Published in:
- Medicinal Research Reviews, 2012, v. 32, n. 3, p. 659, doi. 10.1002/med.20226
- By:
- Publication type:
- Article
6
Protein Tyrosine Phosphatase 1B Inhibitors: A Molecular Level Legitimate Approach for the Management of Diabetes Mellitus.
- Published in:
- Medicinal Research Reviews, 2012, v. 32, n. 3, p. 459, doi. 10.1002/med.20219
- By:
- Publication type:
- Article
7
Peptide-mediated targeted drug delivery.
- Published in:
- Medicinal Research Reviews, 2012, v. 32, n. 3, p. 637, doi. 10.1002/med.20225
- By:
- Publication type:
- Article